GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » Equity-to-Asset

Neurotech International (ASX:NTI) Equity-to-Asset : 0.95 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Neurotech International Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Neurotech International's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$4.80 Mil. Neurotech International's Total Assets for the quarter that ended in Dec. 2023 was A$5.07 Mil. Therefore, Neurotech International's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.95.

The historical rank and industry rank for Neurotech International's Equity-to-Asset or its related term are showing as below:

ASX:NTI' s Equity-to-Asset Range Over the Past 10 Years
Min: -7.98   Med: 0.85   Max: 0.96
Current: 0.95

During the past 7 years, the highest Equity to Asset Ratio of Neurotech International was 0.96. The lowest was -7.98. And the median was 0.85.

ASX:NTI's Equity-to-Asset is ranked better than
98.16% of 869 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs ASX:NTI: 0.95

Neurotech International Equity-to-Asset Historical Data

The historical data trend for Neurotech International's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International Equity-to-Asset Chart

Neurotech International Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Equity-to-Asset
Get a 7-Day Free Trial 0.46 -7.98 0.77 0.71 0.75

Neurotech International Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.94 0.71 0.96 0.75 0.95

Competitive Comparison of Neurotech International's Equity-to-Asset

For the Medical Devices subindustry, Neurotech International's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurotech International's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neurotech International's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Neurotech International's Equity-to-Asset falls into.



Neurotech International Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Neurotech International's Equity to Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Equity to Asset (A: Jun. 2023 )=Total Stockholders Equity/Total Assets
=3.962/5.309
=0.75

Neurotech International's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=4.795/5.07
=0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurotech International  (ASX:NTI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Neurotech International Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Neurotech International's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurotech International (ASX:NTI) Business Description

Traded in Other Exchanges
N/A
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Neurotech International (ASX:NTI) Headlines

From GuruFocus

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend 08-17-2013

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson 11-09-2013

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend 01-17-2013

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend 11-12-2014